High-choline Diets Ameliorate Acute Graft-Versus-host Disease

Bo Hu,Depei Wu,Yang Xu
DOI: https://doi.org/10.1097/bs9.0000000000000061
2020-01-01
Blood Science
Abstract:Allogeneic hematopoietic stem cell transplantation (alloHSCT) is one of the most effective methods in the treatment of leukemia and other malignant hematological diseases. However, the occurrence of acute graft-versus-host disease (aGVHD) seriously impairs the survival and prognosis of patients, and the mortality rate of aGVHD is about 10%. During the development of aGVHD, the initial step consists of injury to the host tissues caused by conditioning regimen. Increasing reports have indicated that gastrointestinal toxicity, in turn, could aggravate aGVHD through modulating the severity of intestinal inflammation. The gut mucosal damage mediated by aGVHD causes the bacterial translocation which further stimulates antigen presenting cells thereby upregulates the production of pro-inflammatory cytokines such as interleukin1 (IL-1) and interleukin-6 (IL-6). This proinflammatory process provides appropriate environment for T-cell allo-activation and has been proposed to play a particularly critical role in the initial stage of aGVHD. In addition, the alterations in the compositions of intestinal microbiota after allo-HSCT has also been shown to be closely associated with the onset of aGVHD. The loss of microbial diversity can result in the relative abundance of pathogenic bacteria and the loss of Clostridia species, which is considered to be benefit for the proliferation and activation of regulatory T cells (Treg cells). This imbalance of the gut microbiota finally breaks the immune homeostasis and promotes the development of aGVHD. Besides the loss of bacterial diversity and alteration of bacterial composition, the variety of microbial metabolites after alloHSCT has also been shown to play an important role in aGVHD.
What problem does this paper attempt to address?